Team Grant : Diabetes Mechanisms and Translational Solutions – Full Application = Relaunched
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with your unit
Memorial Deadline: Tuesday 6th, July 2021
External Deadline: Tuesday 13th, July 2021
Description
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them.
In 2021, Canada will celebrate the 100th anniversary of the discovery of insulin, for which Drs. Banting and Macleod received a Nobel Prize – an illustrious moment for Canadians and one of the most dramatic examples of rapid translation of a discovery in basic science into a benefit for patients. Despite this discovery and the subsequent progress that has been made in treating diabetes, the burden of diabetes on individuals, families, communities and health care systems is increasing in Canada and around the world, as are the related complications. In October 2018, CIHR held the 100 Years of Insulin: What’s Next? Workshop to identify scientific priorities to advance diabetes research, with the ultimate goal of developing ways to reduce the burden of disease for diabetes patients and their families. The scientific priorities identified at the Workshop, along with input from partners and stakeholders led to the development of the 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes Initiative.
As part of 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, the Team Grants in Diabetes Mechanisms and Translational Solutions will support multi-disciplinary research to better understand the underlying causes and pathophysiology of diabetes, and develop improved prevention and treatment approaches for diabetes. For the purposes of this Initiative, diabetes includes all forms of diabetes mellitus, its complications and co-morbidities. Mechanistic research is defined as studies designed to understand the pathophysiology of diabetes, its complications and co-morbidities. Translational research is defined as research that advances effective translation and application of knowledge across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes.
Patient engagement is a requirement for this funding opportunity. Patient engagement is about meaningful collaboration between researchers and patients, in this case, people with diabetes representative of the population being studied. Recognizing that with some types of research it may be easier to engage patients than with other types of research, people with diabetes should be engaged as appropriate for the type of research being proposed, for example, by contributing to identifying research questions and priority setting, and contributing to governance of the research and even performing certain parts of the research itself. This type of participation helps to ensure that the research being conducted is relevant and valuable to the people that it affects. People with diabetes engaged in research proposals can also collaborate with the research team to summarize or share the results with target audiences (especially other people with diabetes) and with policy-makers or other decision-makers who may apply the results in a health or community setting. For more information about the full scope of patient engagement, please see CIHR’s Patient Engagement Framework.
Additional Partner Funding Eligibility
FRQS
- For Quebec eligibility requirements for individuals, refer to the Common general rules on the FRQS web site.
- FRQS applicants invited to submit a full proposal must also submit a budget to FRQS. A specific FRQS form will be sent to applicants.
- Early career researchers are encouraged to submit an application as a Principal Applicant.
Mitacs
- Applicants must contact a Mitacs’ Business Development representative by September 18, 2020. The Mitacs representative will share the Mitacs Application Form and provide support in its completion.
- Mitacs will confirm eligibility and compliance with Accelerate and/or Elevate program requirements.
- Once the form is completed, applicants must then send it back to a Mitacs’ Business Development representative so they can pre-review the information for completeness.
- Applicants must include the requested intern(s) on their budget and the completed Mitacs Application Form with their CIHR full application (see How to Apply section).
Additional information can be found at Research Net.